10.1002/ejoc.202000708
European Journal of Organic Chemistry
FULL PAPER
CHH, Bn), 4.04 (dd, J = 9.5, 8.5 Hz, 1H; H-3), 3.87 – 3.79 (m, 2H; H-5;
H-5’), 3.83 (dd, J = 9.9, 8.8 Hz; H-3’), 3.75 (dd, J = 10.0, 8.5 Hz, 1H; H-4),
3.63 (dd, J = 10.4, 2.0 Hz, 1H; H-6a), 3.57 (dd, J = 9.5, 3.5 Hz, 1H; H-2),
3.45 – 3.41 (m, 1H; H6b), 3.44 (s, 3H; CH3O), 3.38 (dd, J = 9.9, 3.5 Hz,
1H; H-2’), 3.12 (dd, J = 9.5, 8.8 Hz, 1H; H-4’), 1.44 (dd, J = 14.9, 4.0 Hz,
1H; H-6a’), 0.97 (dd, J = 14.9, 9.1 Hz, 1H; H-6b’), 0.35 (s, 3H; CH3Si), 0.32
(s, 3H; CH3Si). 13C NMR (126 MHz, CDCl3) δ 139.8 (CAr,q), 139.2 (CAr,q),
138.9 (CAr,q), 138.8 (CAr,q), 138.2 (CAr,q), 138.2 (CAr,q), 138.2 (CAr,q), 133.8,
129.0, 128.6, 128.5, 128.4, 128.4, 128.4, 128.3, 128.1, 128.0, 128.0, 127.9,
127.7, 127.6, 127.6, 127.1, 126.8 [aromatic C atoms], 97.7 (C-1), 95.1
(C-1’), 85.0 (C-4’), 82.2 (C-3), 81.5 (C-3’), 80.3 (C-2’), 80.1 (C-2), 75.5
(CH2, Bn), 75.3 (CH2, Bn), 74.3 (CH2, Bn), 73.4 (CH2, Bn), 73.4 (CH2, Bn),
73.0 (CH2, Bn), 72.0 (C-4), 70.0, 69.6 [C-5, C-5’], 69.4 (C-6), 55.2 (CH3O),
20.1 (C-6’), −0.8 (CH3Si), −1.6 (CH3Si). HR-MS: [M+Na]+ calcd for
C63H70NaO10Si: 1037.4636; found: 1037.4627.
Bn], 70.3 [one out of C-3, C-4, C-3’, C-5’], 69.2 (C-6), 55.1 (CH3O), 51.0
(C-2), 23.6 (CH3CO), 19.9 (C-6’), −0.9 (CH3Si), −1.5 (CH3Si).
Methyl 2’,3’,4’-tri-O-benzyl-6’-deoxy-6’-dimethylphenylsilyl-β-D-glu-
copyranosyl-(1’→4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-gluco-
pyranoside (29b). Rf 0.22 (PE/acetone, 7:3); 1H NMR (500 MHz, CDCl3)
δ 7.49 – 7.44 (m, 2H; HCAr), 7.39 – 7.18 (m, 28H; HCAr), 5.18 (d, J = 8.3
Hz, 1H; NH), 4.95 (d, J = 12.4 Hz, 1H; CHH, Bn), 4.88 (d, J = 11.1 Hz, 1H;
CHH, Bn), 4.86 – 4.82 (m, 2H; 2×CHH, Bn), 4.80 (d, J = 3.7 Hz, 1H; H-1),
4.79 – 4.73 (m, 2H; 2×CHH, Bn), 4.66 (d, J = 11.2 Hz, 1H; CHH, Bn), 4.62
(d, J = 12.1 Hz, 1H; CHH, Bn), 4.55 (d, J = 12.4 Hz, 1H; CHH, Bn), 4.40
(d, J = 12.1 Hz, 1H; CHH, Bn), 4.28 (d, J = 7.5 Hz, 1H; H-1’), 4.14 (ddd, J
= 10.8, 8.3, 3.7 Hz, 1H; H-2), 3.98 (dd, J = 10.1, 8.8 Hz, 1H; H-4), 3.82 (dd,
J = 10.9, 3.2 Hz, 1H; H-6a), 3.53 (ddd, J = 10.1, 3.2, 2.4 Hz, 1H; H-5), 3.51
– 3.47 (m, 1H; H-6b), 3.46 (dd, J = 10.8, 8.8 Hz, 1H; H-3), 3.42 – 3.34 (m,
2H; H-3’; H-2’), 3.32 (s, 3H; CH3O), 3.23 (ddd, J = 10.9, 9.0, 1.7 Hz, 1H;
H-5’), 3.13 (dd, J = 9.0, 8.7 Hz, 1H; H-4’), 1.86 (s, 3H; CH3CO), 1.38 (dd,
J = 14.9, 1.7 Hz, 1H; H-6a’), 0.72 (dd, J = 14.9, 10.9 Hz, 1H; H-6b’), 0.31
(s, 3H; CH3Si), 0.26 (s, 3H; CH3Si). 13C NMR (126 MHz, CDCl3) δ 169.8
(C=O), 139.6 (CAr,q), 139.5 (CAr,q), 138.8 (CAr,q), 138.7 (CAr,q), 138.6 (CAr,q),
138.0 (CAr,q), 133.8 (2×CArH), 128.9 (CArH), 128.6 (2×CArH), 128.5 (CArH),
128.5 (2×CArH), 128.5 (2×CArH), 128.4 (2×CArH), 128.4 (2×CArH), 128.3
(2×CArH), 128.2 (2×CArH), 128.0 (2×CArH), 127.9 (2×CArH), 127.9 (2×CArH),
127.8 (2×CArH), 127.8 (CArH), 127.7 (CArH), 127.7 (CArH), 127.5 (CArH),
102.0 (C-1’), 98.4 (C-1), 84.7, 84.6 [2 peaks: C-3’; C-4’], 83.6 (C-2’), 77.8
(C-3), 76.4 (C-4), 75.7 (CH2, Bn), 75.3 (CH2, Bn), 75.1 (CH2, Bn), 74.4
(CH2, Bn), 73.6 (CH2, Bn), 72.9 (C-5’), 70.8 (C-5), 67.7 (C-6), 55.3 (CH3O),
52.8 (C-2), 23.5 (CH3CO), 18.5 (C-6’), −1.4 (CH3Si), −2.7 (CH3Si).
Methyl 2’,3’,4’-tri-O-benzyl-6’-deoxy-6’-dimethylphenylsilyl-β-D-glu-
copyranosyl-(1’→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (28b). Rf
0.43 (PE/EtOAc, 4:1); 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.20 (m, 35H;
HCAr), 5.03 (d, J = 11.0 Hz, 1H; CHH, Bn), 4.93 (d, J = 11.2 Hz, 1H; CHH,
Bn), 4.88 – 4.69 (m, 8H; CHH, Bn), 4.63 (d, J = 3.7 Hz, 1H; H-1), 4.62 (d,
J = 11.9 Hz; CHH, Bn), 4.38 (d, J = 12.1 Hz, 1H; CHH, Bn), 4.23 (d, J =
7.0 Hz, 1H; H-1’), 3.91 (dd, J = 10.1, 9.1 Hz, 1H; H-4), 3.81 (dd, J = 9.7,
9.1 Hz, 1H; H-3), 3.77 (dd, J = 10.8, 2.9 Hz, 1H; H-6a), 3.54 (ddd, J = 10.1,
2.9, 1.6 Hz, 1H; H-5), 3.49 (dd, J = 9.7, 3.7 Hz, 1H; H-2), 3.45 – 3.40 (m,
1H; H-6b), 3.41 (s, 3H; CH3O), 3.38 – 3.30 (m, 2H; H-2’; H-4’), 3.24 (ddd,
J = 11.1, 9.1, 1.5 Hz, 1H; H-5’), 3.16 (dd, J = 8.8 Hz, 1H; H-3’), 1.40 (dd, J
= 14.8, 1.5 Hz, 1H; H-6a’), 0.78 (dd, J = 14.8, 11.1 Hz, 1H; H-6b’), 0.31 (s,
3H; CH3Si), 0.24 (s, 3H; CH3Si). 13C NMR (126 MHz, CDCl3) δ 139.8 (CAr,q),
139.7 (CAr,q), 138.9 (CAr,q), 138.8 (CAr,q), 138.7 (CAr,q), 138.6 (CAr,q), 137.6
(CAr,q), 133.8 (2×CArH), 128.9 (CArH), 128.7 (2×CArH), 128.6 (2×CArH),
128.6 (2×CArH), 128.5 (2×CArH), 128.5 (2×CArH), 128.5 (2×CArH), 128.3
(2×CArH), 128.0 (CArH), 128.0 (2×CArH), 128.0 (2×CArH), 127.9 (2×CArH),
127.9 (2×CArH), 127.8 (CArH), 127.8 (2×CArH), 127.8 (CArH), 127.7 (CArH),
127.6 (CArH), 127.2 (CArH), 101.8 (C-1’), 98.8 (C-1), 84.6, 84.5, 83.5 [C-2’;
C-3’; C-4’], 80.6 (C-3), 78.2 (C-2), 75.8, 75.7, 75.5, 75.3 [3×CH2, Bn; C-4],
74.9 (CH2, Bn), 73.8 (CH2, Bn), 73.7 (CH2, Bn), 72.8 (C-5’), 70.3 (C-5),
67.6 (C-6), 55.4 (CH3O), 18.4 (C-6’), −1.2 (CH3Si), −2.7 (CH3Si). HR-MS:
[M+Na]+ calcd for C63H70NaO10Si: 1037.4636; found: 1037.4627.
2-Methoxyethyl 2,4-di-O-acetyl-3-O-benzyl-6-deoxy-6-dimethylphen-
ylsilyl-L-idopyranosides (30a, 30b). General procedure A with phenyl
2,4-di-O-acetyl-3-O-benzyl-6-deoxy-6-dimethylphenylsilyl-1-thio-L-
idopyranoside (10) (68 mg, 0.120 mmol), 2-methoxyethanol (14) (14 μL,
0.181 mmol), NIS (31 mg, 0.132 mmol) and TfOH (1.1 μL, 0.012 mmol).
The procedure afforded 51 mg (81%; α/β, 93:7) of 30a and 30b after flash
silica column chromatography (PE/EtOAc, 7:3).
2-Methoxyethyl 2,4-di-O-acetyl-3-O-benzyl-6-deoxy-6-dimethylphen-
ylsilyl-α-L-idopyranoside (30a). Rf 0.22 (PE/EtOAc, 3:1); [α]D25 −64.1° (c
0.8, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.47 (m, 2H; HCAr), 7.37
– 7.25 (m, 8H; HCAr), 4.93 (ddd, J = 2.9, 1.6, 0.9 Hz, 1H; H-2), 4.79 (bs,
1H; H-1), 4.71 (d, J = 12.0 Hz, 1H; CHH, Bn), 4.66 – 4.65 (m, 1H; H-4),
4.60 (d, J = 12.0 Hz, 1H; CHH, Bn), 4.45 (ddd, J = 8.5, 6.4, 1.8 Hz, 1H;
H-5), 3.68 (ddd, J = 11.0, 4.6, 4.5 Hz, 1H; CH, aglyc.), 3.66 – 3.64 (m, 1H;
H-3), 3.52 (ddd, J = 11.0, 5.8, 4.4 Hz, 1H; CH, aglyc.), 3.46 – 3.43 (m, 2H;
2×CH, aglyc.), 3.32 (s, 3H; CH3O), 2.07 (s, 3H; CH3CO), 2.05 (s, 3H;
CH3CO), 1.22 (dd, J = 14.8, 8.5 Hz, 1H; H-6a), 1.04 (dd, J = 14.8, 6.4 Hz,
1H; H-6b), 0.34 (s, 3H; CH3Si), 0.33 (s, 3H; CH3Si). 13C NMR (126 MHz,
CDCl3) δ 170.4 (C=O), 169.7 (C=O), 138.6 (CAr,q), 138.1 (CAr,q), 133.7
(2×CArH), 129.2 (CArH), 128.4 (2×CArH), 128.0 (2×CArH), 127.7 (CArH),
127.5 (2×CArH), 98.6 (C-1; 1JC1-H1 = 168.2 Hz, characteristic of an axially
oriented group on C-1), 73.1 (C-3), 71.9 (CH2, Bn), 71.7 (CH2, aglyc.), 70.9
(C-4), 67.6 (CH2, aglyc.), 67.4 (C-2), 63.6 (C-5), 59.3 (CH3O), 21.2
(CH3CO), 21.1 (CH3CO), 18.0 (C-6), −1.7 (CH3Si), −2.6 (CH3Si). HR-MS:
[M+Na]+ calcd for C28H38NaO8Si: 553.2234; found: 553.2220.
Methyl 2’,3’,4’-tri-O-benzyl-6’-deoxy-6’-dimethylphenylsilyl-D-gluco-
pyranosyl-(1’→4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopy-
ranosides (29a, 29b). General procedure B with phenyl 2,3,4-tri-O-ben-
zyl-6-deoxy-6-dimethylphenylsilyl-1-thio-D-glucopyranoside (5) (48 mg,
0.072 mmol), methyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopy-
ranoside (17) (20 mg, 0.048 mmol), NIS (19 mg, 0.079 mmol) and TfOH
(0.7 μL, 0.007 mmol). The procedure afforded 30 mg (60%; α/β, 35:65) of
29a and 29b after flash silica column chromatography (PE/acetone, 7:3).
Methyl 2’,3’,4’-tri-O-benzyl-6’-deoxy-6’-dimethylphenylsilyl-α-D-glu-
copyranosyl-(1’→4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-gluco-
pyranoside (29a). Rf 0.28 (PE/acetone, 7:3); 1H NMR (500 MHz, CDCl3)
δ 7.50 – 7.44 (m, 2H; HCAr), 7.40 – 7.17 (m, 28H; HCAr), 5.47 (d, J = 9.3
Hz, 1H; NH), 5.41 (d, J = 3.5 Hz, 1H; H-1’), 4.91 (d, J = 11.2 Hz, 1H; CHH,
Bn), 4.84 (d, J = 10.8 Hz, 1H; CHH, Bn), 4.73 (d, J = 3.6 Hz, 1H; H-1), 4.71
– 4.43 (m, 8H; CHH, Bn), 4.37 (ddd, J = 10.2, 9.3, 3.6 Hz, 1H; H-2), 3.87
– 3.75 (m, 5H; H-3; H-4; H-5; H-3’; H-5’), 3.61 (dd, J = 10.5, 2.3 Hz, 1H;
H-6a), 3.54 (dd, J = 10.5, 5.6 Hz, 1H; H-6b), 3.40 – 3.36 (m, 1H; H-2’), 3.36
(s, 3H; CH3O), 3.09 (dd, J = 9.1 Hz, 1H; H-4’), 1.87 (s, 3H; CH3CO), 1.42
(dd, J = 15.0, 4.0 Hz, 1H; H-6a’), 0.96 (dd, J = 15.0, 8.7 Hz, 1H; H-6b’),
0.29 (s, 3H; CH3Si), 0.26 (s, 3H; CH3Si). 13C NMR (126 MHz, CDCl3) δ
169.9 (C=O), 139.5 (CAr,q), 138.9 (CAr,q), 138.7 (CAr,q), 138.4 (CAr,q), 138.3
(CAr,q), 138.0 (CAr,q), 133.8, 129.2, 128.5, 128.5, 128.5, 128.5, 128.1, 128.0,
128.0, 128.0, 127.9, 127.8, 127.8, 127.8, 127.7, 127.7, 127.6 [aromatic C
atoms], 98.1 (C-1), 95.7 (C-1’), 84.8 (C-4’), 81.4, 80.0, 79.9 [C-2’; two out
of C-3, C-4, C-3’, C-5’], 75.5 (CH2, Bn), 75.4 (CH2, Bn), 73.4 (CH2, Bn),
72.7 (CH2, Bn), 71.8 [one out of C-3, C-4, C-3’, C-5’], 70.8, 70.7 [C-5; CH2,
2-Methoxyethyl 2,4-di-O-acetyl-3-O-benzyl-6-deoxy-6-dimethylphen-
1
ylsilyl-β-L-idopyranoside (30b). Rf 0.14 (PE/EtOAc, 3:1); H NMR (500
MHz, CDCl3) δ 7.53 – 7.48 (m, 2H; HCAr), 7.38 – 7.24 (m, 8H; HCAr), 4.95
(ddd, J = 2.9, 1.6, 0.9 Hz, 1H; H-2), 4.77 (d, J = 1.6 Hz, 1H; H-1), 4.66 (d,
J = 11.8 Hz, 1H; CHH, Bn), 4.62 (d, J = 11.8 Hz, 1H; CHH, Bn), 4.57 (ddd,
J = 2.5, 1.6, 0.9 Hz, 1H; H-4), 4.03 (ddd, J = 9.4, 5.0, 1.6 Hz, 1H; H-5),
3.95 (ddd, J = 10.6, 4.7, 3.6 Hz, 1H; CHHCH2, aglyc.), 3.78 (dd, J = 2.9,
2.5 Hz, 1H; H-3), 3.62 (ddd, J = 10.6, 7.2, 3.9 Hz, 1H; CHHCH2, aglyc.),
3.64 – 3.48 (m, 2H; 2×CH, aglyc.), 3.35 (s, 3H; CH3O), 2.09 (s, 3H;
CH3CO), 2.05 (s, 3H; CH3CO), 1.35 (dd, J = 14.9, 9.4 Hz, 1H; H-6a), 0.98
(dd, J = 14.9, 5.0 Hz, 1H; H-6b), 0.35 (s, 3H; CH3Si), 0.33 (s, 3H; CH3Si).
13C NMR (126 MHz, CDCl3) δ 170.6 (C=O), 170.4 (C=O), 138.6 (CAr,q),
11
This article is protected by copyright. All rights reserved.